Literature DB >> 17657445

Perceptual variation in categorizing individual peripheral joints for the presence or absence of osteoarthritis using a standard homunculus: observations based on an australian twin registry study of osteoarthritis.

N Bellamy1, A Klestov, K Muirden, P Kuhnert, K A Do, L O'gorman, N Martin.   

Abstract

The clinical diagnosis of osteoarthritis in the peripheral skeleton is dependent on the skilled examination of several features characteristic of the condition. However, we have previously observed that even highly experienced rheumatologists in Australia and Canada may not completely agree on the clinical examination in individuals with osteoarthritis (OA), rheumatoid arthritis, ankylosing spondylitis, fibromyalgia, scleroderma and painful shoulder.

Entities:  

Year:  1999        PMID: 17657445     DOI: 10.1007/s10787-999-0024-x

Source DB:  PubMed          Journal:  Inflammopharmacology        ISSN: 0925-4692            Impact factor:   4.473


  11 in total

Review 1.  Criteria for classification of clinical osteoarthritis.

Authors:  R D Altman
Journal:  J Rheumatol Suppl       Date:  1991-02

2.  Osteoarthritis antirheumatic drug trials. I. Effects of standardization procedures on observer dependent outcome measures.

Authors:  N Bellamy; S Carette; P M Ford; W F Kean; N G le Riche; A Lussier; G A Wells; J Campbell
Journal:  J Rheumatol       Date:  1992-03       Impact factor: 4.666

3.  Bias, prevalence and kappa.

Authors:  T Byrt; J Bishop; J B Carlin
Journal:  J Clin Epidemiol       Date:  1993-05       Impact factor: 6.437

4.  A standardized protocol for measurement of range of movement of the shoulder using the Plurimeter-V inclinometer and assessment of its intrarater and interrater reliability.

Authors:  S Green; R Buchbinder; A Forbes; N Bellamy
Journal:  Arthritis Care Res       Date:  1998-02

5.  Ankylosing spondylitis antirheumatic drug trials. I. Effects of standardization procedures on observer dependent outcome measures.

Authors:  N Bellamy; W W Buchanan; J M Esdaile; A G Fam; W F Kean; J M Thompson; G A Wells; J Campbell
Journal:  J Rheumatol       Date:  1991-11       Impact factor: 4.666

6.  Rheumatoid arthritis antirheumatic drug trials. I. Effects of standardization procedures on observer dependent outcome measures.

Authors:  N Bellamy; T P Anastassiades; W W Buchanan; P Davis; P Lee; G A McCain; G A Wells; J Campbell
Journal:  J Rheumatol       Date:  1991-12       Impact factor: 4.666

7.  Variability of skin scores and clinical measurements in scleroderma.

Authors:  J E Pope; M Baron; N Bellamy; J Campbell; S Carette; I Chalmers; P Dales; J Hanly; E A Kaminska; P Lee
Journal:  J Rheumatol       Date:  1995-07       Impact factor: 4.666

8.  Osteoarthritis antirheumatic drug trials: effects of a standardized instructional videotape on the reliability of observer-dependent dependent outcome measures.

Authors:  N Bellamy; C Bachmeier; P M Brooks; C D Browne; M L Cohen; L March; P G Conaghan; R O Day; J Campbell
Journal:  Inflammopharmacology       Date:  1997       Impact factor: 5.093

9.  Ankylosing spondylitis antirheumatic drug trials: Effects of a standardized instructional viddeotape on the reliability of observer-dependent outcome measures.

Authors:  N Bellamy; K D Muirden; K Boyden; G McColl; H Moran; A Stockman; M M Tellus; I Wicks; J Campbell
Journal:  Inflammopharmacology       Date:  1997       Impact factor: 5.093

10.  Rheumatoid arthritis antirheumatic drug trials: effects of a standardized instructional videotape on the reliability of observer-dependent outcome measures.

Authors:  N Bellamy; K D Muirden; A Bendrups; K Boyden; G McColl; H Moran; A Stockman; M M Tellus; R Travers; J Campbell
Journal:  Inflammopharmacology       Date:  1997       Impact factor: 5.093

View more
  1 in total

1.  Investigating Molecular Signatures Underlying Trapeziometacarpal Osteoarthritis Through the Evaluation of Systemic Cytokine Expression.

Authors:  Anusha Ratneswaran; Jason S Rockel; Daniel Antflek; John J Matelski; Konstantin Shestopaloff; Mohit Kapoor; Heather Baltzer
Journal:  Front Immunol       Date:  2022-01-20       Impact factor: 7.561

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.